{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:00:49Z","timestamp":1761163249321,"version":"build-2065373602"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.semcdb.2023.02.013","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T01:46:08Z","timestamp":1679017568000},"page":"328-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"PC","title":["Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome"],"prefix":"10.1016","volume":"154","author":[{"given":"Chun-Yang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/diaspect.28.2.116","article-title":"The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment","volume":"28","author":"Dennett","year":"2015","journal-title":"Diabetes Spectr."},{"issue":"9","key":"10.1016\/j.semcdb.2023.02.013_bib2","article-title":"The mechanism of androgen actions in PCOS etiology","volume":"7","author":"Rodriguez Paris","year":"2019","journal-title":"Med Sci. (Basel)"},{"issue":"6","key":"10.1016\/j.semcdb.2023.02.013_bib3","first-page":"336","article-title":"Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches","volume":"38","author":"Ndefo","year":"2013","journal-title":"P T"},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib4","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1172\/JCI125755","article-title":"Impact of estrogens in males and androgens in females","volume":"129","author":"Hammes","year":"2019","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.semcdb.2023.02.013_bib5","first-page":"9","article-title":"Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder","volume":"1","author":"Brady","year":"2009","journal-title":"Drug Health Patient Saf."},{"key":"10.1016\/j.semcdb.2023.02.013_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/IJWH.S55748","article-title":"A life course perspective on polycystic ovary syndrome","volume":"6","author":"Sanchez","year":"2014","journal-title":"Int J. Women\u2019s. Health"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib7","first-page":"1","article-title":"Elevated and diagnostic androgens of polycystic ovary syndrome","volume":"19","author":"Abdelazim","year":"2020","journal-title":"Prz. Menopauzalny"},{"key":"10.1016\/j.semcdb.2023.02.013_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"7","key":"10.1016\/j.semcdb.2023.02.013_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17072422","article-title":"Increased risk of polycystic ovary syndrome and it's comorbidities in women with autoimmune thyroid disease","volume":"17","author":"Ho","year":"2020","journal-title":"Int J. Environ. Res Public Health"},{"issue":"6","key":"10.1016\/j.semcdb.2023.02.013_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cen.13828","article-title":"Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews","volume":"89","author":"Gilbert","year":"2018","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"12","key":"10.1016\/j.semcdb.2023.02.013_bib11","first-page":"1378","article-title":"Pathophysiologic mechanisms of obesity- and chronic inflammation-related genes in etiology of polycystic ovary syndrome","volume":"22","author":"Shaaban","year":"2019","journal-title":"Iran. J. Basic Med Sci."},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"J. Ovarian Res"},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052734","article-title":"The role of chronic inflammation in polycystic ovarian syndrome-a systematic review and meta-analysis","volume":"22","author":"Aboeldalyl","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1745505717731971","article-title":"Pregnancy-related outcomes for women with polycystic ovary syndrome","volume":"13","author":"McDonnell","year":"2017","journal-title":"Women\u2019s. Health (Lond. )"},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031221","article-title":"PCOS in adolescents-ongoing riddles in diagnosis and treatment","volume":"12","author":"Meczekalski","year":"2023","journal-title":"J. Clin. Med"},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib16","first-page":"106","article-title":"Diagnosis and treatment of polycystic ovary syndrome","volume":"94","author":"Williams","year":"2016","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib17","first-page":"17","article-title":"Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH","volume":"18","author":"Bani Mohammad","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome: which criteria to use and when?","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/2229-5178.202275","article-title":"Cutaneous manifestations of polycystic ovary syndrome: a cross-sectional clinical study","volume":"8","author":"Keen","year":"2017","journal-title":"Indian Dermatol. Online J."},{"issue":"4","key":"10.1016\/j.semcdb.2023.02.013_bib20","doi-asserted-by":"crossref","first-page":"hoy019","DOI":"10.1093\/hropen\/hoy019","article-title":"Fertility concerns and related information needs and preferences of women with PCOS","volume":"2018","author":"Holton","year":"2018","journal-title":"Hum. Reprod. Open"},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib21","first-page":"627","article-title":"Polycystic ovary syndrome and risk of type 2 diabetes","volume":"70","author":"Zhu","year":"2021","journal-title":"Coron. Heart Dis., Stroke, Diabetes"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-992923","article-title":"Cardiovascular disease risk factors in polycystic ovary syndrome","volume":"26","author":"Dokras","year":"2008","journal-title":"Semin Reprod. Med"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"Should all women with PCOS be treated for insulin resistance?","volume":"97","author":"Marshall","year":"2012","journal-title":"Fertil. Steril."},{"issue":"8","key":"10.1016\/j.semcdb.2023.02.013_bib24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.steroids.2013.04.004","article-title":"Cancer risk and PCOS","volume":"78","author":"Dumesic","year":"2013","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.semcdb.2023.02.013_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.5812\/ijem.4020","article-title":"Cardiovascular risk in women with PCOS","volume":"10","author":"Scicchitano","year":"2012","journal-title":"Int J. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/jomb-2017-0020","article-title":"Women with polycystic ovary syndrome and risk of cardiovascular disease","volume":"36","author":"Blagojevic","year":"2017","journal-title":"J. Med Biochem"},{"issue":"7","key":"10.1016\/j.semcdb.2023.02.013_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2023.02.013_bib29","doi-asserted-by":"crossref","first-page":"34538","DOI":"10.1038\/srep34538","article-title":"Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","article-title":"Dyslipidemia in women with polycystic ovary syndrome","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet. Gynecol. Sci."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/13697137.2017.1316256","article-title":"Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?","volume":"20","author":"Gunning","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.semcdb.2023.02.013_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40738-016-0029-2","article-title":"Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review","volume":"2","author":"Harris","year":"2016","journal-title":"Fertil. Res Pr."},{"issue":"39","key":"10.1016\/j.semcdb.2023.02.013_bib33","article-title":"Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan","volume":"97","author":"Ding","year":"2018","journal-title":"Med. (Baltim. )"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","article-title":"The role of low-grade inflammation in the polycystic ovary syndrome","volume":"335","author":"Repaci","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"issue":"4","key":"10.1016\/j.semcdb.2023.02.013_bib35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonzalez","year":"2012","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.semcdb.2023.02.013_bib36","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2005-2327","article-title":"Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.semcdb.2023.02.013_bib37","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","article-title":"Evidence of proatherogenic inflammation in polycystic ovary syndrome","volume":"58","author":"Gonzalez","year":"2009","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.semcdb.2023.02.013_bib39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/09513590.2012.760195","article-title":"The role of cytokines in polycystic ovarian syndrome","volume":"29","author":"Ebejer","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.semcdb.2023.02.013_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1196\/annals.1365.015","article-title":"Indices of low-grade inflammation in polycystic ovary syndrome","volume":"1092","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ncrna.2023.01.001","article-title":"Signature of micro RNA 146a\/215 and IL-6\/TGF-beta levels in a cross-link axis between obesity and colorectal cancer","volume":"8","author":"Ayeldeen","year":"2023","journal-title":"Noncoding RNA Res"},{"issue":"10","key":"10.1016\/j.semcdb.2023.02.013_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164021","article-title":"High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis","volume":"11","author":"Gao","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.semcdb.2023.02.013_bib43","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib44","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.semcdb.2023.02.013_bib45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum. Reprod. Update"},{"issue":"9","key":"10.1016\/j.semcdb.2023.02.013_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/gtmb.2014.0151","article-title":"Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study","volume":"18","author":"Thathapudi","year":"2014","journal-title":"Genet Test. Mol. Biomark."},{"issue":"11","key":"10.1016\/j.semcdb.2023.02.013_bib47","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10815-013-0080-4","article-title":"TNF-alpha haplotype association with polycystic ovary syndrome - a South Indian study","volume":"30","author":"Deepika","year":"2013","journal-title":"J. Assist Reprod. Genet"},{"issue":"8","key":"10.1016\/j.semcdb.2023.02.013_bib48","first-page":"3761","article-title":"Millan, TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study","volume":"86","author":"Escobar-Morreale","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2023.02.013_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1477-7827-9-131","article-title":"The promoter -1031(T\/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome","volume":"9","author":"Yun","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cyto.2014.05.027","article-title":"Monomeric C-reactive protein and Notch-3 co-operatively increase angiogenesis through PI3K signalling pathway","volume":"69","author":"Boras","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.semcdb.2023.02.013_bib51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.semcdb.2023.02.013_bib52","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib53","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2023.02.013_bib54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.semcancer.2021.01.003","article-title":"Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19","volume":"83","author":"Ahmad","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"Suppl 2","key":"10.1016\/j.semcdb.2023.02.013_bib55","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8 Suppl 2","author":"Gabay","year":"2006","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol."},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148531","article-title":"Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2023.02.013_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1472-6874-14-93","article-title":"Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review","volume":"14","author":"Xu","year":"2014","journal-title":"BMC Women\u2019s. Health"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cyto.2011.09.029","article-title":"Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study","volume":"57","author":"Mirza","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1536\/jhj.45.183","article-title":"Interleukin-6 and cardiovascular diseases","volume":"45","author":"Kanda","year":"2004","journal-title":"Jpn Heart J."},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ncrna.2022.09.007","article-title":"Immunologic response in patients with polytrauma","volume":"8","author":"Mukhametov","year":"2023","journal-title":"Noncoding RNA Res"},{"issue":"23","key":"10.1016\/j.semcdb.2023.02.013_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314574","article-title":"Krivokuca, IL-6 and IL-8: an overview of their roles in healthy and pathological pregnancies","volume":"23","author":"Vilotic","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcdb.2023.02.013_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103155","article-title":"Role of IL-6 signalling in polycystic ovarian syndrome associated inflammation","volume":"141","author":"Borthakur","year":"2020","journal-title":"J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib64","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/jc.2003-031365","article-title":"Millan, Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity","volume":"89","author":"Escobar-Morreale","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.semcdb.2023.02.013_bib65","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","article-title":"Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors","volume":"93","author":"Kaya","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.semcdb.2023.02.013_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7827-9-7","article-title":"Is interleukin-18 associated with polycystic ovary syndrome?","volume":"9","author":"Yang","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"9","key":"10.1016\/j.semcdb.2023.02.013_bib67","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF03350785","article-title":"Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome","volume":"21","author":"Hall","year":"1998","journal-title":"J. Endocrinol. Invest"},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib68","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bpobgyn.2004.05.004","article-title":"The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology","volume":"18","author":"Balen","year":"2004","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.semcdb.2023.02.013_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.667422","article-title":"Central Regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology","volume":"12","author":"Liao","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000489495","article-title":"Elibol, does the pituitary gland volume change in polycystic ovary syndrome?","volume":"83","author":"Bozkurt Koseoglu","year":"2018","journal-title":"Gynecol. Obstet. Invest"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in medical imaging-\"how-to\" guide and critical reflection","volume":"11","author":"van Timmeren","year":"2020","journal-title":"Insights Imaging"},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib72","doi-asserted-by":"crossref","DOI":"10.1177\/0300060521991023","article-title":"Noninvasive radiomics-based method for evaluating idiopathic central precocious puberty in girls","volume":"49","author":"Jiang","year":"2021","journal-title":"J. Int Med Res"},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/23808993.2016.1164013","article-title":"Radiomics: a new application from established techniques","volume":"1","author":"Parekh","year":"2016","journal-title":"Expert Rev. Precis Med Drug Dev."},{"issue":"6","key":"10.1016\/j.semcdb.2023.02.013_bib74","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1148\/rg.326125503","article-title":"Polycystic ovarian syndrome: role of imaging in diagnosis","volume":"32","author":"Lee","year":"2012","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib75","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.fertnstert.2015.08.002","article-title":"Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls","volume":"104","author":"Kenigsberg","year":"2015","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib76","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/radiol.2017161513","article-title":"Polycystic ovary syndrome in adolescents: which mr imaging-based diagnostic criteria?","volume":"285","author":"Fondin","year":"2017","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib77","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1080\/21655979.2021.1979864","article-title":"Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- \u03baB signaling pathway","volume":"12","author":"Ma","year":"2021","journal-title":"Bioengineered"},{"issue":"6","key":"10.1016\/j.semcdb.2023.02.013_bib78","article-title":"Effect of TNF-alpha on endometrial glucose transporter-4 expression in patients with polycystic ovary syndrome through nuclear factor-kappa B signaling pathway activation","volume":"72","author":"Ha","year":"2021","journal-title":"J. Physiol. Pharm."},{"issue":"11","key":"10.1016\/j.semcdb.2023.02.013_bib79","first-page":"3973","article-title":"Vitamin D supplementation inhibits NF-k\u00df signaling pathway in lean and obese women with PCOS","volume":"26","author":"A\u011far","year":"2022","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2022.100671","article-title":"Catalpol attenuates polycystic ovarian syndrome by regulating sirtuin 1 mediated NF-\u03baB signaling pathway","volume":"22","author":"Zhao","year":"2022","journal-title":"Reprod. Biol."},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2022.100679","article-title":"Inhibition of 8-oxoguanine DNA glycosylase (OGG1) expression suppresses polycystic ovarian syndrome via the NF-\u03baB signaling pathway","volume":"22","author":"Xia","year":"2022","journal-title":"Reprod. Biol."},{"issue":"14","key":"10.1016\/j.semcdb.2023.02.013_bib82","doi-asserted-by":"crossref","first-page":"789","DOI":"10.21037\/atm-22-2496","article-title":"Rhamnocitrin decreases fibrosis of ovarian granulosa cells by regulating the activation of the PPAR\u03b3\/NF-\u03baB\/TGF-\u03b21\/Smad2\/3 signaling pathway mediated by Wisp2","volume":"10","author":"Zhou","year":"2022","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.semcdb.2023.02.013_bib83","article-title":"Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-\u03baB\/LCN-2 signaling pathway in inflammatory microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcdb.2023.02.013_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.779718","article-title":"USP25 regulates the proliferation and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by modulating the PI3K\/AKT pathway via deubiquitinating PTEN","volume":"9","author":"Gao","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2021.100594","article-title":"Melatonin alleviates insulin resistance through the PI3K\/AKT signaling pathway in ovary granulosa cells of polycystic ovary syndrome","volume":"22","author":"Guo","year":"2022","journal-title":"Reprod. Biol."},{"issue":"4","key":"10.1016\/j.semcdb.2023.02.013_bib86","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1007\/s12035-021-02714-1","article-title":"Follicular fluid-derived exosomal MicroRNA-18b-5p regulates PTEN-Mediated PI3K\/Akt\/mTOR signaling pathway to inhibit polycystic ovary syndrome development","volume":"59","author":"Zhou","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.semcdb.2023.02.013_bib87","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1507\/endocrj.EJ21-0480","article-title":"Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K\/AKT\/mTOR pathway","volume":"69","author":"Xu","year":"2022","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib88","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10616-022-00528-0","article-title":"Protective effects of lidocaine on polycystic ovary syndrome through modulating ovarian granulosa cell physiology via PI3K\/AKT\/mTOR pathway","volume":"74","author":"Xiong","year":"2022","journal-title":"Cytotechnology"},{"key":"10.1016\/j.semcdb.2023.02.013_bib89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2022.07.006","article-title":"Investigating the effect of Sulforaphane on AMPK\/AKT\/NRF2 pathway in human granulosa-lutein cells under H(2)O(2)-induced oxidative stress","volume":"276","author":"Taheri","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.semcdb.2023.02.013_bib90","doi-asserted-by":"crossref","first-page":"2113293","DOI":"10.1155\/2022\/2113293","article-title":"Curcumin inhibits hyperandrogen-induced IRE1\u03b1-XBP1 pathway activation by activating the PI3K\/AKT signaling in ovarian granulosa cells of PCOS model rats","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.semcdb.2023.02.013_bib91","doi-asserted-by":"crossref","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","article-title":"Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2022.100607","article-title":"MiR-520h inhibits viability and facilitates apoptosis of KGN cells through modulating IL6R and the JAK\/STAT pathway","volume":"22","author":"Huang","year":"2022","journal-title":"Reprod. Biol."},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib93","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.1152\/ajpendo.00150.2022","article-title":"Troxerutin attenuates insulin resistance via pancreatic IL-22\/JAK1\/STAT3 signaling activation in dihydrotestosterone-induced polycystic ovary syndrome rats","volume":"323","author":"Gao","year":"2022","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2023.02.013_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygcen.2022.114138","article-title":"Role and mechanism of the p-JAK2\/p-STAT3 signaling pathway in follicular development in PCOS rats","volume":"330","author":"Wang","year":"2023","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.semcdb.2023.02.013_bib95","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-kappaB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib96","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-kappaB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcdb.2023.02.013_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semcancer.2021.07.015","article-title":"Long non-coding RNAs regulated NF-kappaB signaling in cancer metastasis: micromanaging by not so small non-coding RNAs","volume":"85","author":"Ahmad","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"6","key":"10.1016\/j.semcdb.2023.02.013_bib98","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbalip.2014.12.006","article-title":"PI3K signalling in inflammation","volume":"1851","author":"Hawkins","year":"2015","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.semcdb.2023.02.013_bib99","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2015.05.017","article-title":"PI3K inhibitors in inflammation, autoimmunity and cancer","volume":"23","author":"Stark","year":"2015","journal-title":"Curr. Opin. Pharm."},{"issue":"8","key":"10.1016\/j.semcdb.2023.02.013_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082299","article-title":"Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment","volume":"19","author":"Kasembeli","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib101","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1080\/21655979.2021.2003943","article-title":"Aberrant activation of the Hedgehog signaling pathway in granulosa cells from patients with polycystic ovary syndrome","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"},{"issue":"4","key":"10.1016\/j.semcdb.2023.02.013_bib102","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S0967199422000028","article-title":"The expression profile of WNT\/\u03b2-catanin signalling genes in human oocytes obtained from polycystic ovarian syndrome (PCOS) patients","volume":"30","author":"Ismail","year":"2022","journal-title":"Zygote"},{"issue":"8","key":"10.1016\/j.semcdb.2023.02.013_bib103","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1210\/clinem\/dgac281","article-title":"Elevated levels of follicular fatty acids induce ovarian inflammation via ERK1\/2 and inflammasome activation in PCOS","volume":"107","author":"Lai","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib104","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10735-022-10096-4","article-title":"Roles of HIF-1\u03b1\/BNIP3 mediated mitophagy in mitochondrial dysfunction of letrozole-induced PCOS rats","volume":"53","author":"Wang","year":"2022","journal-title":"J. Mol. Histol."},{"issue":"11","key":"10.1016\/j.semcdb.2023.02.013_bib105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/09513590.2022.2125951","article-title":"Aberrant BMP15\/HIF-1\u03b1\/SCF signaling pathway in human granulosa cells is involved in the PCOS related abnormal follicular development","volume":"38","author":"Cao","year":"2022","journal-title":"Gynecol. Endocrinol."},{"issue":"8","key":"10.1016\/j.semcdb.2023.02.013_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081037","article-title":"Notch signaling induced by endoplasmic reticulum stress regulates cumulus-oocyte complex expansion in polycystic ovary syndrome","volume":"12","author":"Koike","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.semcdb.2023.02.013_bib107","first-page":"882","article-title":"Astragaloside IV regulates autophagy-mediated proliferation and apoptosis in a rat model of PCOS by activating the PPAR\u03b3 pathway","volume":"25","author":"Wen","year":"2022","journal-title":"Iran. J. Basic Med Sci."},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12860-022-00449-y","article-title":"High levels of follicular fluid testosterone could impair oocyte developmental competency via affecting aryl hydrocarbon receptor pathway in PCOS patients","volume":"23","author":"Eini","year":"2022","journal-title":"BMC Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13048-022-00962-w","article-title":"Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis","volume":"15","author":"Zou","year":"2022","journal-title":"J. Ovarian Res"},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40199-021-00413-9","article-title":"Repurposing new drug candidates and identifying crucial molecules underlying PCOS pathogenesis based on bioinformatics analysis","volume":"29","author":"Dehghan","year":"2021","journal-title":"Daru"},{"issue":"12","key":"10.1016\/j.semcdb.2023.02.013_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12480","article-title":"Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders","volume":"8","author":"Hossain","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.semcdb.2023.02.013_bib112","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.3390\/cancers3032955","article-title":"Mechanisms and therapeutic implications of cell death induction by indole compounds","volume":"3","author":"Ahmad","year":"2011","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.semcdb.2023.02.013_bib113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4155\/fmc-2018-0371","article-title":"Gaze through the clinical lens: molecular and clinical advancements of botanicals","volume":"11","author":"Farooqi","year":"2019","journal-title":"Future Med Chem."},{"issue":"1","key":"10.1016\/j.semcdb.2023.02.013_bib114","doi-asserted-by":"crossref","first-page":"2160569","DOI":"10.1080\/13510002.2022.2160569","article-title":"Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K\/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue","volume":"28","author":"Rabah","year":"2023","journal-title":"Redox Rep."},{"issue":"5","key":"10.1016\/j.semcdb.2023.02.013_bib115","doi-asserted-by":"crossref","DOI":"10.2196\/15094","article-title":"Identifying women at risk for polycystic ovary syndrome using a mobile health app: virtual tool functionality assessment","volume":"4","author":"Rodriguez","year":"2020","journal-title":"JMIR Form. Res"},{"key":"10.1016\/j.semcdb.2023.02.013_bib116","doi-asserted-by":"crossref","DOI":"10.1007\/s10815-023-02724-z","article-title":"Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS","author":"Yang","year":"2023","journal-title":"J. Assist Reprod. Genet"}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952123000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952123000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:21:11Z","timestamp":1761067271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952123000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":116,"alternative-id":["S1084952123000423"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2023.02.013","relation":{},"ISSN":["1084-9521"],"issn-type":[{"type":"print","value":"1084-9521"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2023.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}